UnitedHealth Is Approaching a Pivotal Moment. Should Investors Buy the Stock Before July 29?

It's been an awful, horrible, lousy year so far for UnitedHealth Group (NYSE: UNH). If I opened a thesaurus, I could easily find plenty of other apt descriptions for the healthcare giant's performance over the last seven months.However, UnitedHealth is scheduled to report its second-quarter results in just one week -- before the market opens on July 29. This update could be a pivotal moment for the company. Should investors buy the stock before July 29? UnitedHealth Group heads into its Q2 update with decidedly low expectations. The company pulled its full-year guidance in May due to higher-than-anticipated Medicare Advantage costs, and the consensus among analysts surveyed by LSEG is for UnitedHealth to report revenue of $111.75 billion. This number is roughly 13% higher than the company's revenue in the prior-year period. Could such solid revenue growth be enough to ignite a rally for the beaten-down stock? Probably not.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool